| 000 -LEADER |
|---|
| fixed length control field |
00711 a2200193 4500 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
151231b xxu||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780080983509 |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
615.19 |
| 100 ## - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Riley, Christopher M.(ed.) |
| 245 ## - TITLE STATEMENT |
|---|
| Title |
Specification of Drug Substances and Products: Development and Validation of Analytical Methods |
| Statement of responsibility, etc |
ed. by Christopher M. Riley, Thomas W. Rosanske and Shelley R. Rabel Riley |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Name of publisher, distributor, etc |
Elsevier |
| Date of publication, distribution, etc |
2014 |
| Place of publication, distribution, etc |
Amsterdam |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
380p. |
| 600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Drugs Analysis |
| 9 (RLIN) |
371 |
| 600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Drugs Standards |
| 9 (RLIN) |
375 |
| 600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Drug development |
| 9 (RLIN) |
372 |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Rosanske, Thomas W.(ed.) |
| 9 (RLIN) |
376 |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Riley, Shelley R. Rabel(ed.) |
| 9 (RLIN) |
377 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
|
| Item type |
Book |
| Call number prefix |
615.19 |
| Call number suffix |
SPE |
